Puma Biotechnology, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PBYI Nasdaq 2830 www.pumabiotechnology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Puma Biotechnology, Inc.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2025 3:03 pm
Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek - Jul 2nd, 2025 6:34 am
RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance - Jul 1st, 2025 9:55 am
Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention? - Jun 30th, 2025 12:24 pm
Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why - Jun 30th, 2025 8:40 am
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - Jun 27th, 2025 7:40 am
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma - Jun 19th, 2025 9:11 am
Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Jun 11th, 2025 7:40 am
With 57% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) boasts of strong institutional backing - Jun 10th, 2025 5:11 am
Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? - May 26th, 2025 7:40 am
3 Promising Penny Stocks With Market Caps Under $200M - May 20th, 2025 12:08 pm
Puma Biotechnology's (NASDAQ:PBYI) Earnings Are Of Questionable Quality - May 15th, 2025 5:30 am
Puma Biotechnology First Quarter 2025 Earnings: Beats Expectations - May 10th, 2025 8:54 am
PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates - May 9th, 2025 6:48 am
Puma Biotechnology Inc (PBYI) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges - May 9th, 2025 1:39 am
Puma Biotech: Q1 Earnings Snapshot - May 8th, 2025 2:52 pm
Puma Biotechnology Reports First Quarter Financial Results - May 8th, 2025 2:05 pm
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? - May 5th, 2025 7:15 am
Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients - Apr 30th, 2025 4:00 am
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Apr 28th, 2025 1:03 pm